Replies to post #140263 on Biotech Values

[bladerunner1717]

jq1234,

Don't you consider the partnership with MRK to be some form of validation of the drug and the technology. $120 million up front and a 50-50 profit split in the U.S. is not such a bad deal. Do you agree?


Bladerunner